Using MC1R Genotype to Impact Melanoma Risk Behavior

NCT03509467 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2054

Last updated 2025-12-19

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to examine how different messages about risk of melanoma can impact the way people protect themselves against developing these diseases.

Conditions

Interventions

BEHAVIORAL

Personalized Information

Personalized information about ways that participants can protect themselves and their child from developing melanoma.

BEHAVIORAL

Standard Information

Standard information about ways that participants can protect themselves and their child from developing melanoma.

OTHER

DNA Extraction Determination of MC1R Genotypes

After signing informed consent, a biologic sample (saliva) will be collected for the purpose of DNA extraction determination of MC1R genotypes. All participants who carry high risk MC1R genotypes and a proportion of those who carry low risk or no MC1R variants will be randomized to the control or intervention arm.

Sponsors & Collaborators

  • Ponce Health Sciences University

    collaborator OTHER
  • University of South Florida

    collaborator OTHER
  • American Cancer Society, Inc.

    collaborator OTHER
  • H. Lee Moffitt Cancer Center and Research Institute

    lead OTHER

Principal Investigators

  • Peter Kanetsky, Ph.D · H. Lee Moffitt Cancer Center and Research Institute

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-08-03
Primary Completion
2021-02-19
Completion
2021-02-19

Countries

  • United States
  • Puerto Rico

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03509467 on ClinicalTrials.gov